erythropoiesis-stimulating agents
Showing 1 - 25 of 8,067
Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis
Not yet recruiting
- Erythropoietin Resistant Anemia (EPO Resistant Anemia)
- (no location specified)
Sep 22, 2023
Erythropoiesis Stimulating Agents for Anemia Management in
Completed
- Anemia of Chronic Kidney Disease
- +2 more
-
Giza, Egyptthe Memorial Souad Kafafi University Hospital
Jan 24, 2023
Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)
Suspended
- Anemia of Chronic Kidney Disease
-
Hackensack, New JerseyResearch Site
Aug 23, 2022
End Stage Renal Disease Trial in Kaohsiung (AI (model))
Completed
- End Stage Renal Disease
- AI (model)
-
Kaohsiung, TW, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
Aug 31, 2021
End Stage Renal Disease on Dialysis Trial in Kaohsiung, (novel artificial intelligence assisted platform)
Recruiting
- End Stage Renal Disease on Dialysis
- novel artificial intelligence assisted platform
-
Kaohsiung,, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
Oct 5, 2021
MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)
Recruiting
- Myelodysplastic Syndromes (MDS)
- Sodium Valproate, Bezafibrate, Medroxyprogesterone
- Danazol
-
Dudley, England, United Kingdom
- +7 more
Aug 12, 2022
Anemia Trial in Palma de Mallorca (Paricalcitol, Epoetin beta, Placebo)
Recruiting
- Anemia
- Paricalcitol
- +2 more
-
Palma de Mallorca, Islas Baleares, SpainSon Espases University Hospital
Mar 3, 2021
Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)
Terminated
- Anemia
- Dialysis-Dependent Chronic Kidney Disease
- vadadustat
- epoetin alfa
-
Bakersfield, California
- +17 more
Feb 2, 2021
Chronic Kidney Disease Hyporesponsive Anemia to Erythropoiesis
Completed
- Renal Anemia
- Chronic Kidney Disease
-
Niigata, JapanNiigata University Graduate School of Medicine
Jun 17, 2020
Anemia, Renal Insufficiency, Chronic Trial in Japan (Molidustat (BAY85-3934))
Completed
- Anemia
- Renal Insufficiency, Chronic
- Molidustat (BAY85-3934)
-
Kasuya-gun, Fukuoka, Japan
- +19 more
Jan 28, 2021
Kidney Failure, Chronic, Hemodialysis Trial in Beijing (Human Erythropoiesis Injection (CHO cell), Recombinant Erythropoiesis
Recruiting
- Kidney Failure, Chronic
- Hemodialysis
- Human Erythropoiesis Injection (CHO cell)
- Recombinant Erythropoiesis Stimulating Protein Injection(CHO cell)
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jan 13, 2022
Standard-of-care Erythropoiesis-stimulating Agents on Forearm
Completed
- Cardiovascular Diseases
- Chronic Kidney Disease
- Darbepoetin Alfa
- +3 more
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Jan 7, 2020
Anemia of Chronic Kidney Disease Trial in Hackensack (vadadustat)
Suspended
- Anemia of Chronic Kidney Disease
-
Hackensack, New JerseyResearch Site
Aug 23, 2022
MDS Trial in Worldwide (Talacotuzumab, Daratumumab)
Completed
- Myelodysplastic Syndromes
-
Saint Louis, Missouri
- +20 more
Dec 28, 2022
Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)
Recruiting
- Anemia in Dialysis-dependent CKD Patients
-
Alexandria, EgyptAlexandria University
Oct 29, 2023
Anemia, Renal Insufficiency, Chronic Trial in Japan (Molidustat (BAY85-3934), Darbepoetin alfa, Placebo of Molidustat
Completed
- Anemia
- Renal Insufficiency, Chronic
- Molidustat (BAY85-3934)
- +3 more
-
Nagoya, Aichi, Japan
- +52 more
Jan 28, 2021
Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,
Completed
- Hyperphosphatemia
- +2 more
- Ferric Citrate 1 gram Oral Tablet
- Standard of care phosphate-lowering therapy
-
Anchorage, Alaska
- +12 more
Nov 3, 2022
MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)
Recruiting
- Myelodysplastic Syndromes
- Canakinumab Injection
- Darbepoetin Alfa
-
Tampa, FloridaMoffitt Cancer Center
Nov 21, 2022
Anemia, Renal Insufficiency, Chronic Trial in Japan (Molidustat (BAY85-3934), Darbepoetin alfa)
Completed
- Anemia
- Renal Insufficiency, Chronic
- Molidustat (BAY85-3934)
- Darbepoetin alfa
-
Yatomi, Aichi, Japan
- +58 more
Jan 28, 2021
Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)
Not yet recruiting
- Anemia, Sickle Cell
- Sickle Cell Disease
- Hydroxyurea
- Epoetin Alfa
-
Pittsburgh, Pennsylvania
- +1 more
Aug 4, 2022